GLP-3 (retatrutide) is an investigational triple-agonist peptide that activates three of the body's most powerful metabolic receptors at once — GLP-1, GIP, and glucagon. It slows gastric emptying, reduces appetite, improves insulin sensitivity, and boosts fat burn.
Patients self-inject once per week. Most notice reduced cravings within 7–14 days, with steady fat loss in the first month as your provider titrates the dose.
Reduces appetite
Acts on hunger centers in the brain.
Stabilizes blood sugar
Improves insulin response.
Increases fat burn
Glucagon boosts metabolic energy use.
Supports heart health
Improved lipids and blood pressure.

Verified Result
Sarah K.
"I had struggled with binge eating for almost a decade. Within the first two weeks the constant food noise just quieted. I am down 22 pounds in 4 months and finally feel in control around food again."
Sarah K.
Verified patient · 4 mo